Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Opioid Use Disorder (OUD) Market Size From 2025 to 2034?

The market size for opioid use disorder (oud) has experienced significant growth in recent years. It is projected to increase from $3.96 billion in 2024 to $4.37 billion in 2025, at a compound annual growth rate (CAGR) of 10.5%. Factors such as higher prescription rates, pain management protocols, drug promotion, and the stigma associated with addiction have contributed to the growth in the historical period.

The market for opioid use disorder (oud) is predicted to experience substantial expansion in the impending years, and it is projected to reach$6.91 billion by 2029 with a compound annual growth rate (CAGR) of 12.1%. This anticipated growth within the forecast period can be credited to regulatory actions, emphasis on alternative pain management solutions, extension of treatment accessibility, and public health initiatives. Foreseeable trends within the forecast period include advancements in treatment technology, personalized treatment strategies, combined care frameworks, community-oriented support schemes, as well as early detection and prevention.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Opioid Use Disorder (OUD) Market?

The surge in opioid addiction incidents is anticipated to drive the expansion of the opioid use disorder (OUD) market in the future. Opioid addiction is a medical issue defined by obsessive and constant opioid intake which poses detrimental impacts on the body. The continued utilization of opioids, which can generate sensations of euphoria and alleviate pain, can result in the buildup of tolerance. This requires larger doses to elicit the same response, potentially leading to opioid use disorder. For instance, the Centers for Disease Control and Prevention, a public health agency based in the US, reported in March 2024 that the synthetic opioid overdose rate had escalated by 4.1%, rising from 21.8 to 22.7 between 2021 and 2022. Thus, the escalating count of opioid addiction instances stimulates the expansion of the opioid use disorder (OUD) market.

Which Key Market Segments Comprise the Opioid Use Disorder (OUD) Market and Drive Its Revenue Growth?

The opioid use disorder (oud)market covered in this report is segmented –

1) By Drug Type: Buprenorphine; Naltrexone; Methadone

2) By Route of Administration: Oral; Parenteral

3) By Age Group: 19 To 40; 41 To 60; 61 And Over

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies And Stores; Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone; Buprenorphine Tablets; Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets; Vivitrol

3) By Methadone: Methadone Tablets; Methadone Oral Solution

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

Which Areas Are Leading Regions in the Opioid Use Disorder (OUD) Market Expansion Across the Globe?

North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Strategic Trends Steering theOpioid Use Disorder (OUD) Market Direction?

A prominent trend gaining traction within the opioid use disorder (OUD) market is product innovation. To maintain their market standings, top businesses functioning within the OUD sector are focusing on developing novel products. For example, in May 2023, Brixadi (buprenorphine), an extended-release injection for treating moderate to severe OUD, gained approval from the U.S. Food and Drug Administration, a federal agency based in the U.S. Brixadi comes in two dosage forms: a weekly injection for patients who have commenced treatment with a single dose of a transmucosal buprenorphine product or are already on the medication, and a monthly version for those presently under the medication.

View the full report here:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

How Is the Opioid Use Disorder (OUD) Market Conceptually Defined?

Opioid use disorder (OUD) is a chronic brain disease resulting from prolonged use of opioids, including both prescription painkillers and illegal opioids. Opioid use disorder can develop due to genetic, environmental, and behavioral factors.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12586

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model